A migraine is a recurring neurological disorder characterized by unilateral, intense, and pulsatile headaches. In one-third of migraine patients, the attacks are preceded by a visual aura, such as a slowly-propagating scintillating scotoma. Migraine aura is thought to be a result of the neurovascular phenomenon of cortical spreading depression (SD), a self-propagating wave of depolarization that spreads across the cerebral cortex. Several animal experiments have demonstrated that cortical SD causes intracranial neurogenic infl ammation around the meningeal blood vessels, such as plasma protein extravasation and pro-inflammatory peptide release. Cortical SD has also been reported to activate both peripheral and central trigeminal nociceptive pathways. Although several issues remain to be resolved, recent evidence suggests that cortical SD could be the initial trigger of intracranial neurogenic inflammation, which then contributes to migraine headaches via subsequent activation of trigeminal afferents.
Introduction
Cortical spreading depression (SD), described first by Leao [1] , is a self-propagating wave of transient neuronal/ glial membrane depolarization that is accompanied by a transient negative shift of the direct current (DC) potential [2] and temporal elevation of cerebral blood flow (CBF) [3, 4] throughout the cerebral hemisphere at a rate of 2-5 mm/ min [1, 5, 6] . The rate of spreading correlates with the observed spread of the aura of a classical migraine [7] , which is characterized by a spot of fl ickering light that appears near the center of the visual field and then gradually expands outward [8] [9] [10] . Recently, cortical SD has been hypothesized to be the initial event involved in migraine headaches.
Moskowitz et al. [11, 12] proposed that pro-inflammatory peptides, such as substance P and calcitonin generelated peptide (CGRP), released from trigeminocervical nerve terminals in response to some unknown stimulation, probably cortical SD, induces vasodilation and plasma protein extravasation. Such neurogenic inflammation is thought to trigger a headache via stimulation of trigeminal afferents. Consistent with this hypothesis, cortical SD induced intracranial neurogenic inflammation around the meningeal blood vessels [13] [14] [15] , and subsequent activation of both peripheral [16] and central [17] trigeminal nociceptive pathways has been described. Here, we review the experimental evidence mainly from neurophysiological studies that has advanced the understanding of whether and how the neurovascular phenomenon of cortical SD causes intracranial neurogenic inflammation, and subsequently participates in triggering a migraine headache.
Migraine Pathophysiology
A migraine is a recurring neurological disorder characterized by unilateral, intense, and pulsatile headaches lasting 4-72 h [18] , and is often associated with symptoms including nausea, vomiting, and sensitivity to light, sound, or smell [19] .
In one-third of migraine patients, the attack is preceded by transient neurological symptoms like sensory or motor deficits, collectively referred to as a migraine aura [9, 20, 21] .
Most common is a visual aura, a scintillating scotoma, in which a spot of fl ickering light appears near the center of the visual fi eld and then gradually expands outward [8] [9] [10] .
Several theories have been proposed to explain the pathophysiology of migraine: the vascular, neural, and trigeminovascular theories. In the 1930s, Harold Wolff [22] and colleagues proposed the vascular theory, wherein the neurological symptoms of migraine aura are caused by cerebral vasoconstriction, and the migraine pain is evoked by vasodilatation of the extracranial terminal branches of the external carotid artery. They found that the intensity of migraine pain is closely related to the amplitude of pulsation in the occipital and superfi cial temporal branches of the external carotid arteries [22] . In the 1980s, Olesen and colleagues found the presence of spreading oligemia, a 20%-30% reduction of cerebral blood flow that appears first in the posterior part of the brain and then gradually spreads into the parietal and temporal lobes at a rate of 2-3 mm/min during an episode of migraine with aura [8, 23, 24] .
The spread of oligemia does not match the territories of the major cerebral arteries, but follows the cortical surface, implying a neural, rather than a vascular cause [23] . A highly variable increase in the cerebral blood fl ow is often followed by oligemia [25, 26] , but the periods of increased cerebral blood fl ow do not correlate temporally with the experience of migraine headache [8, 23, 27] , suggesting that the intracranial vasodilation is likely an epiphenomenon, rather than a cause of the migraine headache.
In 1941, Karl Spencer Lashley [10] , a psychologist at Harvard University, described his own experience of a visual aura, where a scotoma started as a small area, then gradually enlarged, and spread toward the periphery of the visual fi eld, and the propagation rate was estimated to be 3 mm/min or less. Three years later, Aristides Leao [1] reported the phenomenon of cortical SD, characterized by a self-propagating wave of depolarization that begins in the neuronal/glial cells of local areas of the brain and subsequently spreads in all directions at a rate of ~3 mm/ min. The similarity of Lashley's migraine aura and Leao's cortical SD was first picked up by Milner in 1958 [7] , and further investigated by Olesen in the 1980s, as described above. Based on both Lashley's description of a spreading scotoma [10] and Leao's findings of cortical SD [1] , the pathogenic theories changed from primary vascular to primary neural mechanisms.
In the 1980s, Moskowitz and colleagues reconciled the primary vascular and primary neural views and proposed the trigeminovascular theory [11, 12] . They hypothesized that some unknown stimulation, probably the cortical SD, depolarizes the trigeminocervical nerve terminals innervating the meninges, and pro-inflammatory peptides such as substance P and CGRP are released from the primary meningeal afferents, which further induce vasodilation and plasma protein extravasation. Such neurogenic infl ammatory reactions were thought to trigger headache via stimulation of the trigeminal afferents.
Supporting this theory, plasma extravasation was observed during electrical stimulation of the trigeminal ganglion in the rat [11] , and pro-inflammatory peptides including CGRP and substance P were released in response to electrical stimulation of the trigeminal ganglion in humans and cats [28] . Moreover, the theory was supported by clinical studies where the CGRP levels were found to be increased in the jugular vein of patients during migraine attacks [29] , and vasogenic leakage from the leptomeningeal vessels has also been shown in at least one case of migraine with aura [30] , two cases of prolonged migraine aura and during spontaneous or familial hemiplegic migraine attacks [31, 32] .
Leao's Cortical Spreading Depression
The mysterious phenomenon of cortical SD was first identified in the rabbit cerebral cortex by Aristides
Leao, a young Brazilian neurophysiologist, during his
Ph.D. fellowship in the Department of Physiology at
Harvard University [1] . At that time, Leao was studying the electroencephalogram (EEG) of experimental epilepsy in the cerebral cortex of an anesthetized rabbit, but he was distracted by a contradictory and unexpected result that the EEG activity was silenced for a minute, and such suppression propagated slowly across the cerebral hemisphere. This phenomenon was then extensively studied around the world [33] [34] [35] [36] , and has been characterized as a self-propagating wave of depolarization associated with a transient negative shift of the DC potential [2] and temporal elevation of the CBF [3, 4] . These changes in DC potential and CBF spread throughout the cortical gray matter at a rate of ~3 mm/min [1, 5, 6] .
Cortical SD can be evoked by tetanic electrical stimuli, mechanical stimuli such as pressure on or puncture of the cortex, alkaline pH, low osmolarity, and chemical stimuli such as potassium ions or glutamate [36] [37] [38] . Recently, we demonstrated that transient tissue oxidation in a restricted local area of the rat cerebral cortex also induces cortical SD [3] . To restrict oxidation within a sub-millimeter region,
we used a unique technique, photo-dynamic tissue oxidation (PDTO) technique, developed by Kataoka et al.
for assessing the spatially-and temporally-controlled brain tissue oxidation from outside the brain within seconds or minutes [39] . PDTO was carried out by application of rose Bengal, a photo-sensitizing dye, to a discrete region of the brain, followed by photo-irradiation through the dura mater. We found a high-amplitude DC potential shift (~50 mV) in the photo-oxidized area, and such a shift of the DC potential recovered gradually over the next 3 h (Fig. 1 ) [3] .
A series of DC potential negative shifts with an amplitude of approximately -25 mV was observed in the surrounding area, indicating that a representative cortical SD was induced by prolonged and synchronized membrane depolarization in the photo-irradiated area [3] .
The propagation of cortical SD is thought to involve the release and diffusion of some excitatory chemical mediators, most likely K + and glutamate, into the interstitial fluid [40] . Mechanisms that modulate cortical excitability have been demonstrated to contribute to cortical SD propagation, such as the local distribution of astrocytes, which is known to stabilize the extracellular milieu [38, 41] .
Astrocytes have been reported to remove K + from the extracellular space by several mechanisms, including inwardly-rectifying K + channels, the Na + /K + -ATPase and Na + -K + -Cl -co-transporters, and spatial K + buffering via gap junctions [42, 43] . Indeed, astrocytes have been reported to prevent the occurrence of SD through spatial buffering of the extracellular K + [44] . Moreover, several studies have reported that the spread of SD stops where white matter 
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begins and at the edge of glial-fi brous scars left by previous injury or infarction [45, 46] . Consistent with these observations, we also demonstrated that the velocity of cortical SD gradually decreases from the dorsal to the ventral cortical areas of the insular cortex, in which the volume distribution of astrocyte is known to gradually increase.
Recently, we have also demonstrated that the brain serotonergic system, which is known to modulate the excitability of cortical neurons through activation of several receptor subtypes, in particular, 5-HT1A, 5-HT2A, and 5-HT3 receptors [47] [48] [49] , contributes to the propagation of cortical SD. Pyramidal neurons in the cerebral cortex express 5-HT1A and 5-HT2A receptors, which exert opposing effects on the excitability and firing activity of pyramidal neurons [47, 49] . Activation of 5-HT1A receptors hyperpolarizes, whereas activation of 5-HT2A receptors depolarizes pyramidal neurons [47] [48] [49] . On the other hand, 5-HT2A receptors are expressed in large and 5-HT3
receptors in small GABAergic interneurons [50] . The activation of the excitatory receptors 5-HT2A and 5-HT3
in GABAergic interneurons directly excites GABAergic interneurons, and indirectly inhibits the fi ring of pyramidal neurons in the cortex and hippocampus [51, 52] . Although the activation of 5-HT2A receptors in pyramidal neurons results in the activation of neurons, a preferential inhibitory action of 5-HT has been reported in vivo [48] . Such a preferential inhibitory action of 5-HT on cortical neurons could be explained by the different binding affinities of 5-HT for 5-HT1A and 5-HT2 receptors. Hoyer et al. [53] reported that 5-HT has a much higher binding affinity for 5-HT1A than 5-HT2 receptors in the cerebral cortex. We also found that the propagation velocity of cortical SD is increased, possibly by extending the width of the depolarization wave, in neonatal rats treated with 5,7-dihydroxytryptamine [54] , in which the serotonergic innervation in the cerebral cortex is chronically decreased due to pharmacological degeneration of the dorsal raphe serotonergic neurons (Fig. 2) . These results indicate that the excitability of the cerebral cortex might be increased by chronic dysfunction of serotonergic innervation in the cerebral cortex, and such a mechanism would explain the facilitation of migraine with a low serotonin disposition. Likewise, increased excitability of the cerebral cortex caused by gene mutation, such as missense mutation of CACNA1A (encoding the α 1 subunit of neuronal Cav2.1(P/Q-type) calcium channels), a representative gene mutation in familial hemiplegic migraine (FHM) families, induces migraine susceptibility by lowering the threshold of cortical SD generation [55] .
Cortical SD Induces Neurogenic Infl ammation in Rat Cerebral Cortex
Cortical SD is thought to be a trigger of neurogenic inflammation around meningeal blood vessels, and then evokes headache pain via the activation of trigeminal afferents [11, 12, 56] . Bolay et al. [13] demonstrated that cortical SD causes vasodilation of the middle meningeal artery and subsequent plasma protein leakage mediated by the release of pro-infl ammatory peptides from trigeminal axon collaterals innervating the meninges. Further evidence [15] supports the idea that a long-lasting (up to 48 h) disruption of the blood-brain barrier can be induced by cortical SD, due to activation of the matrix metalloproteinase-9 (MMP-9) cascade. The MMP-9 levels increase from 3 to 6 h after the induction of cortical SD in the ipsilateral cerebral hemisphere, reaching a maximum at 24 h and persisting for at least 48 h [15] . Plasma protein leakage and brain edema are also contemporaneous 3 h after cortical SD induction.
These observations suggest that the plasma protein extravasation and pro-infl ammatory peptides release from primary meningeal afferents might be a pivotal step in the cortical SD-induced neurogenic infl ammatory process and subsequent headache. However, confl icts exist, as several drugs that selectively inhibit plasma protein extravasation in rodents have failed to reduce the pain severity in patients with migraine as evidenced by the failure in clinical trials of substance P and neurokinin-1 antagonists [57] and specific plasma protein extravasation blockers such as 4991w93 [58] and cp122,288 [59] . Such contradictory evidence indicates that an appropriate method is necessary to investigate whether and how the neuroinflammation is involved in migraine etiology and to verify the extrapolated data from animal studies for the human condition. 11 C]CLINME have been widely used for studying brain infl ammation [60] [61] [62] [63] . The principal immune cells in the central nervous system, microglia, are activated in response to inflammatory processes in the brain [64] . The process of microglial activation is thought to be related to an increase in the number of microglia and the expression of numerous proteins such as the peripheral benzodiazepine receptor (PBR) [65] . The PBR is a mitochondrial outer membrane protein, and is expressed at a low level on resting microglia and astrocytes in the normal brain. Its expression is upregulated in activated microglia [66] [67] [68] , and the upregulation is well correlated with the state of activation [69] [70] [71] . 11 C-labeled PK11195 is a specific PET ligand for PBR to image activated microglia in the brain, and has been extensively used for quantitative evaluation of brain infl ammation by PET in a number of neurological disorders, such as stroke [72] , multiple sclerosis [69] , Alzheimer disease [73] , Parkinson disease [74] and Huntington disease [75] .
Using [ 11 C]PK11195-PET imaging in rats, we demonstrated that unilateral cortical SD induces neurogenic inflammation in the ipsilateral cerebral hemisphere [14] . The highest 
Cortical SD Activates the Trigeminal Nociceptive Pathway in the Rat Brain
Migraine headaches are thought to be triggered by brain inflammation that activates trigeminal nociceptors in meningeal blood vessels [76] . However, it is still controversial whether the neurogenic inflammation induced by cortical 
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SD is able to activate the trigeminal nociceptive pathway.
Recently, Moskowitz and colleagues demonstrated that c-Fos expression in the trigeminal nucleus caudalis (TNC), the first central site of the trigeminal nociceptive pathway, is significantly increased by cortical SD, and this increase is abolished by trigeminal rhizotomy [56] . Moreover, cortical SD-evoked single neuron activity in the trigeminal ganglion (peripheral pathway) and the TNC has also been demonstrated directly by electrophysiological studies [17] . Such activation was observed as a two-fold increase in ~50% of neurons in the trigeminal ganglion and TNC, and persisted for 45 min or longer. However, confl icting reports have shown that the cortical SD does not induce sustained neuronal activity recorded mainly in the deeper laminae of the more rostral trigeminal nucleus up to several hours after either a single or even a series of cortical SD inductions in the rat [77, 78] .
We recently developed a small-animal neuroimaging
PET imaging with statistical parametric mapping analysis to evaluate the regional activity in the entire rat brain.
Using the FDG-PET imaging method, we found that cortical SD activates the trigeminal nociceptive pathway, including both second-order and high-order nuclei, such as the thalamus and somatosensory cortex, ~40 h after the induction of unilateral cortical SD (unpublished data).
Consistently, several electrophysiological studies have reported that neurons in the high-order nuclei of the trigeminal nociceptive pathway are activated in response to inflammatory stimuli applied to the meninges [79, 80] . A juxtacellular recording study has further revealed that the [14] ). S1BF), trunk region of the primary somatosensory cortex, secondary somatosensory cortex, insula, primary visual cortex and primary auditory cortex [81] . Taken together, these observations suggest that cortical SD is able to activate the trigeminal nociceptive pathway and might contribute to migraine headache.
Summary
A migraine headache is a complex neurobiological disorder that has been hypothesized to be caused by 
